APUS 株価推移チャート
APUS 株価予測
Apimeds Pharmaceuticals US Inc
$0
0%
$0
終値： Apr 28, 16:00:00 GMT-4
$0
0%
$0
プレマーケット： Apr 29, 04:47:32 GMT-4
戻る
Apimeds Pharmaceuticals US Inc (APUS) 株価予測
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
配当利回り
--
1株当たり利益(TTM)
--
時価総額
--
APUSとは何ですか？
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
